|LETTER TO THE EDITOR
|Year : 2020 | Volume
| Issue : 4 | Page : 359
Pregnant women and corona virus disease-2019 outbreaks: What they need to know
Saurabh RamBihariLal Shrivastava1, Prateek Shrivastava2
1 Member of the Medical Education Unit and Institute Research Council, Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth – Deemed to be University, Kancheepuram, Tamil Nadu, India
2 Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth – Deemed to be University, Kancheepuram, Tamil Nadu, India
|Date of Submission||15-Mar-2020|
|Date of Decision||16-Mar-2020|
|Date of Acceptance||21-May-2020|
|Date of Web Publication||17-Jun-2020|
Dr. Saurabh RamBihariLal Shrivastava
Professor, Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth (SBV) – Deemed to be University, Tiruporur - Guduvancherry Main Road, Ammapettai, Nellikuppam, Chengalpaet District, Kancheepuram - 603 108, Tamil Nadu
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Shrivastava SR, Shrivastava P. Pregnant women and corona virus disease-2019 outbreaks: What they need to know. Iranian J Nursing Midwifery Res 2020;25:359
|How to cite this URL:|
Shrivastava SR, Shrivastava P. Pregnant women and corona virus disease-2019 outbreaks: What they need to know. Iranian J Nursing Midwifery Res [serial online] 2020 [cited 2020 Jul 13];25:359. Available from: http://www.ijnmrjournal.net/text.asp?2020/25/4/359/287032
The ongoing Corona Virus Disease-2019 (COVID-19) pandemic has questioned the preparedness of all the nations in the effective containment of the disease. The global estimates depict that a total of 1991562 cases and 130885 deaths (case fatality rate - 6.57%) has been reported in 213 nations and territories.
At present, the clinical spectrum of disease is not so clear among pregnant women, nevertheless, no striking variability has been observed between pregnant and non-pregnant women with regard to the clinical manifestations. The available evidence suggests that the chances of the mother-to-child transmission of the causative virus during the period of pregnancy is remote. Nevertheless in the post-natal period, a newborn is susceptible to acquire the infection.
Even though it has been reported that very small number of newborns have tested positive for the virus soon after birth, it is yet to be confirmed whether they acquired the virus before or after birth. Also, the virus has not been detected in amniotic fluid, breast milk, or other maternal samples. Similar results were obtained in a cohort of COVID-19 positive pregnant women in China, wherein the virus was not isolated in the amniotic fluid, cord blood or throat swabs taken from the neonates., Furthermore, even the samples of breast milk have tested negative for the virus, and thus breastfeeding has been recommended as per the universal norms, provided women strictly adhere to the infection prevention and control guidelines (like hand washing, regular disinfection of surfaces, etc.) and respiratory hygiene.,,
It is important to acknowledge that pregnancy in itself is a stressful condition and the presence of this novel infection complicates the entire physiological process.,, This calls for the need to offer breastfeeding counseling, provision of psychological and practical assistance to the women to initiate and continue breastfeeding. Moreover, mothers should be sensitized about the infection prevention and control measures and the practice of skin-to-skin contact, rooming-in, and kangaroo mother care all needs to be implemented and encouraged.
In conclusion, the management of COVID-19 infection and pregnancy is a challenge for the health professionals amidst the recent developments. However, till date, as the virus has not been detected in the breast milk and thus breastfeeding should be encouraged in COVID-19 positive pregnant women, with strict adherence to the respiratory hygiene and other infection prevention and control measures.
Financial support and sponsorship
Conflicts of interest
Nothing to declare.
| References|| |
World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 87; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200416-sitrep-87-covid-19.pdf?sfvrsn= 9523115a_2. [Last accessed on 2020 Apr 17].
World Health Organization. Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease is Suspected-Interim Guidance 13 March 2020. Geneva: WHO Press; 2020. p. 1-12.
Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al
. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020;9:51-60.